ImmunoPrecise Antibodies Ltd (IPA)
1.28
+0.02
(+1.59%)
USD |
NASDAQ |
May 03, 16:00
1.26
-0.02
(-1.56%)
After-Hours: 20:00
ImmunoPrecise Antibodies Debt to Equity Ratio: 0.00 for Jan. 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
January 31, 2024 | 0.00 |
October 31, 2023 | 0.00 |
July 31, 2023 | 0.00 |
April 30, 2023 | 0.00 |
January 31, 2023 | 0.00 |
October 31, 2022 | 0.00 |
July 31, 2022 | 0.00 |
April 30, 2022 | 0.0174 |
January 31, 2022 | 0.0271 |
October 31, 2021 | 0.025 |
July 31, 2021 | 0.0242 |
April 30, 2021 | 0.0269 |
January 31, 2021 | 0.0537 |
October 31, 2020 | 0.0667 |
July 31, 2020 | 0.1325 |
April 30, 2020 | 0.174 |
January 31, 2020 | 0.1934 |
October 31, 2019 | 0.1926 |
July 31, 2019 | 0.1844 |
April 30, 2019 | 0.1561 |
January 31, 2019 | 0.1383 |
October 31, 2018 | 0.1317 |
July 31, 2018 | 0.3309 |
April 30, 2018 | 0.2976 |
January 31, 2018 | 0.00 |
Date | Value |
---|---|
October 31, 2017 | 0.00 |
July 31, 2017 | 0.00 |
April 30, 2017 | 0.00 |
January 31, 2017 | 0.0241 |
September 30, 2016 | 0.1941 |
June 30, 2016 | -0.3432 |
March 31, 2016 | -0.32 |
December 31, 2015 | -0.311 |
September 30, 2015 | -0.3362 |
June 30, 2015 | -0.3551 |
March 31, 2015 | -0.3439 |
December 31, 2014 | -0.3547 |
September 30, 2014 | -0.3325 |
June 30, 2014 | -0.6602 |
March 31, 2014 | -0.7777 |
December 31, 2013 | -0.7624 |
September 30, 2013 | -0.8595 |
June 30, 2013 | -0.3512 |
March 31, 2013 | -0.3799 |
December 31, 2012 | -0.2319 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | -0.4171 |
September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jul 2022
0.1934
Maximum
Jan 2020
0.0588
Average
0.025
Median
Oct 2021
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 58.71M |
Total Liabilities (Quarterly) | 21.54M |
Shareholders Equity (Quarterly) | 37.17M |
Current Ratio | 1.657 |